Merck KGaA, DE0006599905

Merck KGaA / DE0006599905

26.07.2024 - 18:50:04

Merck KGaA: Strong 2nd Quarter, Guidance raised

EQS-Ad-hoc: Merck KGaA / Key word(s): Half Year Results


26-Jul-2024 / 18:50 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Darmstadt, July 26, 2024: Based on a very strong second quarter of 2024 with net sales of EUR 5.352 bn resulting in an EBITDA pre1 of EUR 1.509 bn and an EPS pre1 of EUR 2.20, Merck KGaA (the "Company") has further raised its forecast for the entire group for fiscal 2024.  The main driver is a very strong operating performance of Healthcare and Electronics compared to consensus. The performance of Life Science is within expectations. The strong operating performance of Healthcare more than offset the provision equal to a mid-double-digit million euro amount associated with xevinapant. The Company now projects net sales of approx. EUR 20.7 - 22.1 bn (previously EUR 20.6 – 22.1 bn). EBITDA pre1 is anticipated to grow to approx. EUR 5.8 – 6.4 bn for the Group (previously "EUR 5.7 – 6.3 bn"). EPS pre1 is projected to amount to approx. EUR 8.20 – 9.30 (previously "EUR 8.05 – 9.10"). The Company will publish Q2 / 2024 figures as scheduled on 1 August 2024.
1 EBITDA pre and EPS pre are alternative performance measures not defined by international accounting standards, used by the Company to improve the comparability of business performance over time and within the industry. EBITDA pre means earnings before interest, income tax, depreciation and amortization as well as adjustments (Ergebnis vor Zinsen, Ertragsteuern, Abschreibungen und Anpassungen). EPS pre means profit after tax including adjustments per theoretical shares outstanding (see Merck Annual Report 2023).

Esther Döringer
Merck KGaA
Frankfurter Straße 250
64293 Darmstadt
Germany
Phone: +49 151 1454 7809
Email: esther.doeringer@merckgroup.com
Internet: https://www.merckgroup.com/en
ISIN: DE0006599905
WKN: 659990
Indices: DAX
Stock exchanges: Regulated Market of Frankfurt am Main (Prime Standard); Open Markets of Berlin, Düsseldorf, Hamburg, Hanover, Munich, Stuttgart; EUREX derivatives exchange; London, SIX


End of Inside Information

26-Jul-2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com

Language: English
Company: Merck KGaA
Frankfurter Str. 250
64293 Darmstadt
Germany
Phone: +49 (0)6151 72 - 2702
E-mail: insiderregister@merckgroup.com
Internet: https://www.merckgroup.com/de
ISIN: DE0006599905
WKN: 659990
Indices: DAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange; London, SIX
EQS News ID: 1955415

 
End of Announcement EQS News Service

1955415  26-Jul-2024 CET/CEST
fncls.ssp?fn=show_t_gif&application_id=1955415&application_name=news&site_id=trading_house_net~~~7efceac5-959a-43d6-afef-21ad42b6a5d4
@ dgap.de